WASHINGTON, D.C. — The fight against obstructive sleep apnea ... The promise of Zepbound extends even further. By treating both OSA and obesity simultaneously, it may help reduce risks for ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by ... has also approved Zepbound to help with sleep apnea in people with obesity.

Although central sleep apnea isn’t as common, it’s more prevalent in those who suffer from other health conditions. You may like Forget mouth taping to reduce snoring or sleep apnea symptoms ...

Late last year, the FDA approved tirzepatide (Zepbound, Eli Lilly) for adults with moderate to severe obstructive sleep apnea and obesity after the medication showed significantly more efficacy vs.

INDIANAPOLIS (dpa-AFX) - The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea or OSA in adults with obesity ...